FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2529389616> ?p ?o ?g. }

• W2529389616 endingPage "641" @default.
• W2529389616 startingPage "632" @default.
• W2529389616 abstract "Aims The aims of the present study were to assess antiplatelet drug use patterns after a first myocardial infarction (MI) and to evaluate the determinants of antiplatelet nonpersistence. Methods The present study was conducted in 4690 patients from the Utrecht Cardiovascular Pharmacogenetics cohort with a first MI between 1986 and 2010, who were followed for a maximum of 10 years. Medication use and event diagnosis were obtained from the Dutch PHARMO Record Linkage System. Antiplatelet drug users were classified as persistent users (gap between prescriptions ≤90 days), nonpersistent users (>90‐day gap and no refills), and restarters (a new prescription after a >90‐day gap). The association between potential determinants and antiplatelet nonpersistence was analysed using Cox regression. Results The proportions of persistent users decreased from 84.0% at the 1‐year follow‐up to 32.8% at 10 years for any antiplatelet drug, and 77.3% to 27.5% for aspirin; and 39.0% to 6.4% for clopidogrel at 6 years. Most nonpersistent users restarted antiplatelet drugs later, leading to 89.3% overall antiplatelet drug users at 10 years after MI. Diabetes (hazard ratio [HR] 0.44; 0.32–0.60), hypertension (HR 0.77; 0.60–0.99), hypercholesterolaemia (HR 0.49; 0.39–0.62) and more recent MI diagnosis period (2003–2007: HR 0.69, 0.61–0.79; 2008–2010: HR 0.38, 0.19–0.77, compared to ≤ 2002 period) lowered the risk of antiplatelet nonpersistence, while vitamin K antagonist (VKA) comedication (HR 18.97; 16.91–21.28) increased this risk. Conclusions A large proportion of patients with a first MI still used antiplatelet drugs after 10 years. The frequent discontinuations during this time frame are expected to reduce the effectiveness of antiplatelet drugs as secondary prevention of cardiovascular diseases. Diabetes, hypertension, hypercholesterolaemia, VKA comedication and MI diagnosis period were determinants of antiplatelet nonpersistence." @default.
• W2529389616 created "2016-10-14" @default.
• W2529389616 creator A5014475207 @default.
• W2529389616 creator A5031774389 @default.
• W2529389616 creator A5038962814 @default.
• W2529389616 creator A5077437482 @default.
• W2529389616 creator A5084013498 @default.
• W2529389616 date "2016-10-24" @default.
• W2529389616 modified "2023-10-03" @default.
• W2529389616 title "Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period" @default.
• W2529389616 cites W1433020779 @default.
• W2529389616 cites W1971428935 @default.
• W2529389616 cites W1983119331 @default.
• W2529389616 cites W1985354955 @default.
• W2529389616 cites W1998792752 @default.
• W2529389616 cites W2005202304 @default.
• W2529389616 cites W2032603960 @default.
• W2529389616 cites W2041684473 @default.
• W2529389616 cites W2045042595 @default.
• W2529389616 cites W2049791623 @default.
• W2529389616 cites W2058058609 @default.
• W2529389616 cites W2063566560 @default.
• W2529389616 cites W2080339510 @default.
• W2529389616 cites W2090989590 @default.
• W2529389616 cites W2104269881 @default.
• W2529389616 cites W2117254307 @default.
• W2529389616 cites W2118534378 @default.
• W2529389616 cites W2131370832 @default.
• W2529389616 cites W2139189174 @default.
• W2529389616 cites W2158336299 @default.
• W2529389616 cites W2159121887 @default.
• W2529389616 cites W2166950143 @default.
• W2529389616 cites W2194756172 @default.
• W2529389616 cites W2196064518 @default.
• W2529389616 cites W2196303538 @default.
• W2529389616 cites W2884532285 @default.
• W2529389616 cites W4293204946 @default.
• W2529389616 doi "https://doi.org/10.1111/bcp.13139" @default.
• W2529389616 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5306486" @default.
• W2529389616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27662521" @default.
• W2529389616 hasPublicationYear "2016" @default.
• W2529389616 type Work @default.
• W2529389616 sameAs 2529389616 @default.
• W2529389616 citedByCount "5" @default.
• W2529389616 countsByYear W25293896162019 @default.
• W2529389616 countsByYear W25293896162020 @default.
• W2529389616 countsByYear W25293896162023 @default.
• W2529389616 crossrefType "journal-article" @default.
• W2529389616 hasAuthorship W2529389616A5014475207 @default.
• W2529389616 hasAuthorship W2529389616A5031774389 @default.
• W2529389616 hasAuthorship W2529389616A5038962814 @default.
• W2529389616 hasAuthorship W2529389616A5077437482 @default.
• W2529389616 hasAuthorship W2529389616A5084013498 @default.
• W2529389616 hasBestOaLocation W25293896161 @default.
• W2529389616 hasConcept C126322002 @default.
• W2529389616 hasConcept C134018914 @default.
• W2529389616 hasConcept C164705383 @default.
• W2529389616 hasConcept C207103383 @default.
• W2529389616 hasConcept C2426938 @default.
• W2529389616 hasConcept C2776301958 @default.
• W2529389616 hasConcept C2776704044 @default.
• W2529389616 hasConcept C2777265216 @default.
• W2529389616 hasConcept C2777628954 @default.
• W2529389616 hasConcept C2777698277 @default.
• W2529389616 hasConcept C2777849778 @default.
• W2529389616 hasConcept C2779161974 @default.
• W2529389616 hasConcept C2780035454 @default.
• W2529389616 hasConcept C2909112448 @default.
• W2529389616 hasConcept C44249647 @default.
• W2529389616 hasConcept C500558357 @default.
• W2529389616 hasConcept C50382708 @default.
• W2529389616 hasConcept C555293320 @default.
• W2529389616 hasConcept C71924100 @default.
• W2529389616 hasConcept C72563966 @default.
• W2529389616 hasConcept C98274493 @default.
• W2529389616 hasConceptScore W2529389616C126322002 @default.
• W2529389616 hasConceptScore W2529389616C134018914 @default.
• W2529389616 hasConceptScore W2529389616C164705383 @default.
• W2529389616 hasConceptScore W2529389616C207103383 @default.
• W2529389616 hasConceptScore W2529389616C2426938 @default.
• W2529389616 hasConceptScore W2529389616C2776301958 @default.
• W2529389616 hasConceptScore W2529389616C2776704044 @default.
• W2529389616 hasConceptScore W2529389616C2777265216 @default.
• W2529389616 hasConceptScore W2529389616C2777628954 @default.
• W2529389616 hasConceptScore W2529389616C2777698277 @default.
• W2529389616 hasConceptScore W2529389616C2777849778 @default.
• W2529389616 hasConceptScore W2529389616C2779161974 @default.
• W2529389616 hasConceptScore W2529389616C2780035454 @default.
• W2529389616 hasConceptScore W2529389616C2909112448 @default.
• W2529389616 hasConceptScore W2529389616C44249647 @default.
• W2529389616 hasConceptScore W2529389616C500558357 @default.
• W2529389616 hasConceptScore W2529389616C50382708 @default.
• W2529389616 hasConceptScore W2529389616C555293320 @default.
• W2529389616 hasConceptScore W2529389616C71924100 @default.
• W2529389616 hasConceptScore W2529389616C72563966 @default.
• W2529389616 hasConceptScore W2529389616C98274493 @default.
• W2529389616 hasIssue "3" @default.
• W2529389616 hasLocation W25293896161 @default.

• next